Drug application
DIFFERIN (ADAPALENE)
Drugs@FDA NDA 020338 · GALDERMA LABS LP
Key facts
| Drug name | DIFFERIN |
|---|---|
| Active ingredients | ADAPALENE |
| Application type | NDA |
| Application number | 020338 |
| Company | GALDERMA LABS LP |
| Dosage forms | SOLUTION, TOPICAL |
| Strength | 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Marketing status | Discontinued |
| Reference listed drug | Yes |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | May 31, 1996 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
- No FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: